Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria

被引：12
|
作者：
Bonomi, Philip [1 ]
Blumenthal, Gideon [2 ]
Ferris, Andrea Stern [3 ]
Stewart, David J. [4 ]
Selig, Wendy K. D. [5 ]
Krug, Lee M. [6 ]
Allen, Jeff [7 ]
Ison, Gwynn [2 ]
Langer, Corey J. [8 ]
Melemed, Allen [9 ]
Odogwu, Lauretta [2 ]
Roy, Upal Basu [3 ]
Sandler, Alan [10 ]
机构：
[1] Rush Presbyterian St Lukes Med Ctr, Chicago, IL USA
[2] US FDA, Silver Spring, MD USA
[3] LUNGev Fdn, Bethesda, MD USA
[4] Univ Ottawa, Ottawa, ON, Canada
[5] WSCollaborative, Mclean, VA USA
[6] Bristol Myers Squibb, Princeton, NJ USA
[7] Friends Canc Res, Washington, DC USA
[8] Univ Penn, Philadelphia, PA 19104 USA
[9] Eli Lilly, Indianapolis, IN USA
[10] Genentech Inc, San Francisco, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 06期
关键词：
ONCOLOGY;
D O I：
10.1016/j.jtho.2018.02.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：748 / 751
页数：4
相关论文
共 50 条
  • [1] Clinical trials require more-inclusive eligibility criteria
    Nature Reviews Urology, 2015, 12 (12) : 653 - 653
  • [2] Reappraisal of eligibility criteria in cancer clinical trials
    Penel, Nicolas
    Lebellec, Loic
    Vanseymortier, Marie
    CURRENT OPINION IN ONCOLOGY, 2018, 30 (05) : 352 - 357
  • [3] Recommendations for Broadening Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials
    Siegel, Corey A.
    Rai, Victoria
    Outtier, An
    Vermeire, Severine
    Law, Cindy C. W.
    Sands, Bruce E.
    Abdulhamid, Asim
    Gearry, Richard
    McGuire, Josh
    Lindsay, James O.
    Panaccione, Remo
    Schweistein, Hagai
    Dotan, Iris
    Scarallo, Luca
    Griffiths, Anne
    Dubinsky, Marla C.
    JOURNAL OF CROHNS & COLITIS, 2024,
  • [4] Reducing patient eligibility criteria in cancer clinical trials
    George, SL
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1364 - 1370
  • [5] A systematic review of eligibility criteria for phase II clinical trials for patients with lung cancer
    Doherty, Gary
    Ogunmwonyi, Innocent
    Shotton, Rohan
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 46 - 46
  • [6] Uptake of recommendations for broadening clinical trial eligibility criteria for patients with brain metastasis and leptomeningeal disease in lung cancer clinical trials: A systematic review
    Riano, Ivy
    Velez, Maria Antonia
    Pomares-Millan, Hugo
    Manana, Ana I. Velazquez
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement
    Kim, Edward S.
    Uldrick, Thomas S.
    Schenkel, Caroline
    Bruinooge, Suanna S.
    Harvey, R. Donald
    Magnuson, Allison
    Spira, Alexander
    Wade, James L.
    Stewart, Mark D.
    Vega, Diana Merino
    Beaver, Julia A.
    Denicoff, Andrea M.
    Ison, Gwynn
    Ivy, S. Percy
    George, Suzanne
    Perez, Raymond P.
    Spears, Patricia A.
    Tap, William D.
    Schilsky, Richard L.
    CLINICAL CANCER RESEARCH, 2021, 27 (09) : 2394 - 2399
  • [8] Impact of Prior Cancer on Eligibility for Lung Cancer Clinical Trials
    Gerber, David E.
    Laccetti, Andrew L.
    Xuan, Lei
    Halm, Ethan A.
    Pruitt, Sandi L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (11):
  • [9] Eligibility criteria in clinical trials in breast cancer: a cohort study
    Szlezinger, Katarzyna
    Pogoda, Katarzyna
    Jagiello-Gruszfeld, Agnieszka
    Klosowska, Danuta
    Gorski, Andrzej
    Borysowski, Jan
    BMC MEDICINE, 2023, 21 (01)
  • [10] Eligibility criteria in clinical trials in breast cancer: a cohort study
    Katarzyna Szlezinger
    Katarzyna Pogoda
    Agnieszka Jagiełło-Gruszfeld
    Danuta Kłosowska
    Andrzej Górski
    Jan Borysowski
    BMC Medicine, 21
12345